ARPC3P2

Across TCGA pan-cancer cohorts, ARPC3P2 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of ARPC3P2’s most consistent transcriptional readouts.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where ARPC3P2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ARPC3P2 is over-expressed in tumor.

UCEC, KIRP, and COAD are the cancer types where ARPC3P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ARPC3P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
UCEC	All	All	+0.268	.005	6	view →
KIRP	All	All	+0.125	.007	6	view →
COAD	All	II,III,IV	+0.475	<.001	5	view →
BRCA	All	All	+0.105	.001	4	view →
KIRC	All	All	+0.060	.009	4	view →
PAAD	Male	All	+0.225	.023	2	view →
LUAD	All	All	+0.143	.003	2	view →
PRAD	All	All	+0.066	.030	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

ARPC3P2–UCEC

Open the UCEC breakdown →